Chapter 358: JPMorgan Chase's Choice (Part II)

"Are you sure you're not kidding? A foreign businessman has advanced biotechnology far beyond that of the United States? How do I feel like a ridiculous situation in a superhero movie?" questioned an old man who looked to be about sixty years old. Pen | fun | pavilion www. biquge。 info

He obviously has a lot of common problems with white Americans, that is, arrogance, and stubbornly believes that the world's most cutting-edge technology must belong to the "great" lighthouse countries, and some powerful countries may be able to barely catch up with their butts, but they will never be able to surpass them.

Also as a white American, Schneider's natural way of nature is what is going on in the other person's mind, and unceremoniously sarcastically said: "I'm sorry, Mr. Adam, if your mind was still stuck thirty years ago, then any technology is not much different from a superhero movie for you now." Keep in mind that what I have just described is not some kind of futuristic fantasy, but an implementation that is already in front of you. Not only does the other side have more advanced biotechnology, but we can't even reverse crack it. ”

The old man, who was called Adam, felt offended, and suddenly stood up and roared, "Bastard, are you insulting my personality?"

"No, sir, I respect your personality, but that doesn't mean I respect your intelligence too!" Schneider replied with a sneer.

Seeing that the two were in a-for-tat stance, Brad hurriedly stood up and slammed the table hard, shouting, "Gentlemen, please stay calm! Especially you, Adam, don't bring pride and prejudice into your work, it can affect our judgment. ”

"I'm sorry, I was a little emotional just now, I apologize. The old man took a deep breath, quickly calmed down and took the initiative to admit his mistake.

Although he was obviously a little unconvinced, he forced himself to endure, and there was a hint of fear of Brad in his eyes.

"I also apologize for the radical remarks just now. Schneider followed the donkey and made a concession attitude, at least on the surface, as for what he thought behind his back, only he knew.

You must know that in large multinational enterprises, all kinds of competition and power struggles emerge one after another, some of which are on the surface, but more of them are hidden under the surface.

In 2012, JPMorgan Chase Bank suffered a huge loss of $2 billion due to hostility among investment executives.

Since then, JPMorgan Chase Bank has been very protective of similar situations, and will give the strongest suppression even if there is even the slightest sign of similarity.

Seeing the two shake hands again, Brad nodded with satisfaction: "Very good! Just now Schneider has shown us the efficacy of that unknown thing, as well as the biotechnology contained in it, I believe everyone has a certain degree of understanding of the value of Alibi Biotechnology Company, to be precise, Mr. Lu." The next step is to assess the risk and profit, and then send the report to the CEO's mailbox before dawn. ”

A middle-aged man in his forties touched his chin and pondered for a few seconds, and then quickly proposed, "Before conducting a risk assessment, I would like to ask a few more professional questions. First, how likely are these technologies to be imitated and cracked? Second, how much does it cost to produce? And finally, does acquiring a stake in Alibis Biotech mean that we can also get these technologies? If not, how can we control the investment risk?"

I have to say that each of these three questions hit the nail on the head, causing a brief silence in the conference room.

After a long while, Schneider was the first to speak: "I'll answer the first question first, judging from the technical level contained in those oval objects, the possibility of being cracked or imitated is basically zero, at least within ten years, there will be no breakthroughs." ”

"I'll answer the remaining two questions. Brad rubbed his somewhat dry eyes and said in a slightly hoarse voice: "During the negotiations this afternoon, the other party mentioned a plan for annual sales of 5.4 billion US dollars, and it is said that the net profit is expected to reach more than 1.5 billion US dollars. Of course, it is likely that R&D expenses are also included. In terms of profitability, it is undoubtedly quite lucrative. As for the technical issues, unfortunately, the other party does not plan to register a patent, but is ready to keep it confidential by means of technical confidentiality, so it is completely impossible to avoid investment risks, but the other party promises to show us some of the core technologies after financing. ”

"Oh my God! Elebi Biotech has only been incorporated for less than a month! They don't even have a sales department! How can they achieve annual sales of $5.4 billion?" Adam questioned loudly.

Brad waved his hand and patiently explained, "No, you don't understand at all, they can do it. Perhaps you have not seen the powerful healing power of those miraculous fruits, so you do not understand its fatal temptation for patients, especially terminally ill patients. But I've seen it, so I understand what a terrifying magic it is. Not to mention 5.4 billion, if the output can keep up, tens of billions a year will not be a problem. ”

"That's right! I saw this afternoon's news interview about a child with advanced leukemia who recovered from critical illness to health in less than a minute after taking the fruit, which is incredible. With something like this, you don't have to worry about sales channels at all. Schneider echoed with a serious face.

The middle-aged man who asked the question before sighed helplessly: "Alas, well, the only thing that can't be solved now is the risk problem." If we can really achieve the net profit of 1.5 billion yuan per year as stated by the other party, then 500 million US dollars and 10 percent of the shares are indeed not expensive, not to mention that we have the conditional of preferential acquisition of 15 to 20 percent of the shares. ”

"So everyone here has agreed in principle to raise money for 50 million dollars and 10 percent of the shares, right?" Brad looked up, patrolling everyone's faces in the room.

"I agree! Eliminate the risk problem, this must be a good business!"

"I agree, too! It must make us a lot of money!"

"Seconded!"

"Seconded!"

......

All of a sudden, everyone expressed their attitudes, and after a while, they unanimously approved the investment intention.

As the leader of the whole project, Brad was very happy with the result, and said with a smile: "Great! Let's work together to complete the risk and return assessment report." The CEO Mr. Jamie Dimon attaches great importance to this investment and has a hunch that it is likely to bring us dozens or even dozens of times the return in the next few years. ”

As the last word of the sentence was blurted out, the conference room quickly fell into a hurry, and after about two hours, a detailed report was finally sent out in the e-mail box......